endpts.com Open in urlscan Pro
99.86.91.20  Public Scan

Form analysis
1 forms found in the DOM

https://endpts.com/

<form action="https://endpts.com/">
  <input type="text" name="s" placeholder="Search">
  <button class="epn_ux_button epn_white epn_search_submit_button"></button>
</form>

Text Content

 * Channels
   * All News
   * In Focus
   * Special
   * AI
   * Bioregnum
   * Biotech Voices
   * Cell/Gene Tx
   * China
   * Coronavirus
   * Deals
   * Diagnostics
   * Discovery
   * FDA+
   * Financing
   * Health Tech
   * Law
   * Letters to the Editor
   * Manufacturing
   * Marketing
   * Nikkei Biotechnology
   * Opinion
   * Outsourcing
   * Peer Review
   * People
   * Pharma
   * R&D
   * Startups
   * Weekly
 * Webinars
 * Biopharma Jobs
 * More
   * Work at Endpoints
   * Letter to Editors
   * Editorial Standards
   * IPO Tracker
   * Webinars
   * Events
   * Sponsored Posts
   * Advertise
   * Privacy Policy
   * Endpoints Merch
   * About Us
   * Help


 * SIGN UP
 * LOG IN



September 16, 2024 09:00 AM EDTUpdated 09:24 AM
People
R&D


MER­CK­'S ELI­AV BARR ON SUB­CU­TA­NEOUS KEYTRU­DA, SUM­MIT AND DEAL SHOP­PING


KYLE LAHUCIK

SENIOR REPORTER

BARCELONA — In the span of 30 min­utes, 29-year Mer­ck vet­er­an Eli­av Barr can
analo­gize drug de­vel­op­ment deal­mak­ing to Reese’s can­dy, call him­self an
“old …


SIGN UP TO READ THIS ARTICLE FOR FREE.

Get free access to a limited number of articles, plus choose newsletters to get
straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER

TRENDING NOW


HERE'S WHAT TO­DAY'S FED RATE CUT MEANS FOR BIOTECH, PHAR­MA AND VEN­TURE
CAP­I­TAL


ALL OF 23AND­ME'S IN­DE­PEN­DENT BOARD MEM­BERS RE­SIGN OVER DIS­AGREE­MENTS
WITH CEO


FDA CAN­CELS AP­PLIED THER­A­PEU­TICS AD­COMM, SHARES SKY­ROCK­ET 65%


WITH FEW EF­FI­CA­CY DE­TAILS, IN­SIL­I­CO CLAIMS A PHASE 2A WIN IN LAT­EST AI
READ­OUT


YOU BET YOUR LIFE: AF­TER I WAS DI­AG­NOSED WITH A RARE CAN­CER, I DIS­COV­ERED
HOW A SMALL BAND OF PHYSI­CIAN-SCI­EN­TISTS ...

sponsored


BREAK­ING DOWN SI­LOS WITH A NEW QUAN­TI­TA­TIVE AP­PROACH TO DRUG
DE­VEL­OP­MENT



Bioscience & Technology Business Center
The University of Kansas
Lawrence, Kansas




LATEST

 * All News
 * Special
 * In Focus
   


CHANNELS

 * AI
 * Bioregnum
 * Biotech Voices
 * Cell/Gene Tx
 * China
 * Coronavirus
 * Deals
 * Diagnostics
 * Discovery
 * FDA+
 * Financing
 * Health Tech
 * Law
 * Letters to the Editor
 * Manufacturing
 * Marketing
 * Nikkei Biotechnology
 * Opinion
 * Outsourcing
 * Peer Review
 * People
 * Pharma
 * R&D
 * Startups
 * Weekly


MORE

 * Work at Endpoints
 * Letter to Editors
 * Editorial Standards
 * IPO Tracker
 * Events
 * Webinars
 * Sponsored Posts
 * Advertise
 * Endpoints Merch
 * About Us
 * Help


WORK IN BIOTECH

 * Endpoints Careers

© Endpoints News 2024

 * Help
 * Advertise
 * Privacy Policy
 * Business Model




LOG IN TO YOUR ACCOUNT


EMAIL




PASSWORD


Change my password Get a magic email link
LOG IN


REQUEST MAGIC LINK

If you're already an Endpoints subscriber, enter your email below for a magic
link that lets you log in quickly without using a password. Please note the
magic link is one-time use only and expires after 24 hours.


EMAIL


BACK
REQUEST


RESET PASSWORD

We'll e-mail you a link to set a new password. Please note this link is one-time
use only and is valid for only 24 hours.


EMAIL


BACK
RESET

SIGN UP FOR FREE TO READ A LIMITED NUMBER OF ARTICLES EACH MONTH.

ABOUT YOU







NEWSLETTER INTERESTS

PICK WHAT NEWSLETTERS GET DELIVERED TO YOUR INBOX EACH WEEK.

Biopharma

ENDPOINTS NEWS Daily at 11:30 AM ET



EARLY EDITION Daily at 7:15 AM ET



ENDPOINTS PHARMA Daily at 3:30 PM ET



BREAKING NEWS ALERTS 2-3 times a week



ENDPOINTS FDA+ Wed at 2 PM ET



ENDPOINTS MANUFACTURING Thu at 2 PM ET



ENDPOINTS WEEKLY Sat at 6 AM ET



POST-HOC 1-2 times a week



Healthcare

ENDPOINTS HEALTH TECH Tuesday, Thursday at 10 AM ET



BREAKING NEWS ALERTS 2-3 times a week


INSTANT SIGN UP

Want unlimited access? Sign up for a premium subscription plan.